CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated  Other Comprehensive Loss	Non-controlling Interest Corporate Joint Venture
Balance, beginning of period (in shares) at Dec. 31, 2019			105,851,285		19,943,432
Balance, beginning of period at Dec. 31, 2019		$ 2,545,712	$ 1	$ 2,097,995	$ (343,524)	$ 782,350	$ 884	$ 8,006
Increase (Decrease) in Stockholders' Equity
Net income		152,865				149,020		3,845
Other comprehensive income		(13)					(13)
Exercise of stock options (in shares)			440,075
Exercise of stock options		7,878		7,878
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		683,255
Issuance of restricted stock units, net of shares withheld for tax	[1]	(8,655)		(8,655)
Warrant exercises		0
Issuance of equity in connection with business combinations (in shares)			28,327,290
Issuance of equity in connection with business combinations		$ 787,877		787,877
Repurchase of common stock (in shares)		5,436,479	5,436,479		5,436,479
Repurchase of common stock		$ (90,163)			$ (90,163)
Common stock surrendered in connection with warrant exercise		0
Issuance of equity in connection with business combinations		5,107		5,107
Stock compensation expense		22,154		22,154
WLH equity award accelerations due to change in control		8,421		8,421
Distributions to non-controlling interests of consolidated joint ventures		(36,301)						(36,301)
Changes in non-controlling interests of consolidated joint ventures		147,253						147,253
Balance, end of period (in shares) at Sep. 30, 2020			129,865,426		25,379,911
Balance, end of period at Sep. 30, 2020		3,542,135	$ 1	2,920,777	$ (433,687)	931,370	871	122,803
Balance, beginning of period (in shares) at Jun. 30, 2020			129,678,751		25,379,911
Balance, beginning of period at Jun. 30, 2020		3,424,740	$ 1	2,915,702	$ (433,687)	816,593	871	125,260
Increase (Decrease) in Stockholders' Equity
Net income		115,199				114,777		422
Exercise of stock options (in shares)			137,553
Exercise of stock options		2,507		2,507
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		49,122
Issuance of restricted stock units, net of shares withheld for tax	[1]	$ (1,403)		(1,403)
Repurchase of common stock (in shares)		0
Repurchase of common stock		$ 0
Issuance of equity in connection with business combinations		(1,301)		(1,301)
Stock compensation expense		5,272		5,272
Distributions to non-controlling interests of consolidated joint ventures		(12,628)						(12,628)
Changes in non-controlling interests of consolidated joint ventures		9,749						9,749
Balance, end of period (in shares) at Sep. 30, 2020			129,865,426		25,379,911
Balance, end of period at Sep. 30, 2020		3,542,135	$ 1	2,920,777	$ (433,687)	931,370	871	122,803
Balance, beginning of period (in shares) at Dec. 31, 2020			129,476,914		25,884,756
Balance, beginning of period at Dec. 31, 2020		3,593,750	$ 1	2,926,773	$ (446,856)	1,025,789	(1,166)	89,209
Increase (Decrease) in Stockholders' Equity
Net income		399,665				390,302		9,363
Exercise of stock options (in shares)			908,221
Exercise of stock options		18,212		18,212
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		388,798
Issuance of restricted stock units, net of shares withheld for tax	[1]	(4,870)		(4,870)
Warrant exercises (in shares)			1,704,205
Warrant exercises		$ 32,584		32,584
Repurchase of common stock (in shares)		8,565,933	8,565,933		8,565,933
Repurchase of common stock		$ (236,831)			$ (236,831)
Common stock surrendered in connection with warrant exercise (in shares)			1,025,699		1,025,699
Common stock surrendered in connection with warrant exercise		(32,587)			$ (32,587)
Stock compensation expense		15,128		15,128
Distributions to non-controlling interests of consolidated joint ventures		(39,155)						(39,155)
Balance, end of period (in shares) at Sep. 30, 2021			122,886,506		35,476,388
Balance, end of period at Sep. 30, 2021		3,745,896	$ 1	2,987,827	$ (716,274)	1,416,091	(1,166)	59,417
Balance, beginning of period (in shares) at Jun. 30, 2021			125,910,318		32,167,192
Balance, beginning of period at Jun. 30, 2021		3,668,849	$ 1	2,977,269	$ (624,615)	1,247,957	(1,166)	69,403
Increase (Decrease) in Stockholders' Equity
Net income		172,467				168,134		4,333
Exercise of stock options (in shares)			276,595
Exercise of stock options		5,778		5,778
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		8,789
Issuance of restricted stock units, net of shares withheld for tax	[1]	$ (13)		(13)
Repurchase of common stock (in shares)		3,309,196	3,309,196		3,309,196
Repurchase of common stock		$ (91,659)			$ (91,659)
Stock compensation expense		4,793		4,793
Distributions to non-controlling interests of consolidated joint ventures		(14,311)						(14,311)
Changes in non-controlling interests of consolidated joint ventures		(8)						(8)
Balance, end of period (in shares) at Sep. 30, 2021			122,886,506		35,476,388
Balance, end of period at Sep. 30, 2021		$ 3,745,896	$ 1	$ 2,987,827	$ (716,274)	$ 1,416,091	$ (1,166)	$ 59,417

[1] Dollar amount represents the value of shares withheld for taxes.